Goldman Sachs’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,814
Closed -$18.2K 4823
2024
Q1
$18.2K Buy
+13,814
New +$18.2K ﹤0.01% 4612
2023
Q2
Sell
-33,571
Closed -$50K 5039
2023
Q1
$50K Buy
+33,571
New +$50K ﹤0.01% 4767
2022
Q4
Sell
-14,263
Closed -$45K 5263
2022
Q3
$45K Sell
14,263
-12,628
-47% -$39.8K ﹤0.01% 5049
2022
Q2
$93K Sell
26,891
-219,230
-89% -$758K ﹤0.01% 5137
2022
Q1
$2.78M Buy
246,121
+70,003
+40% +$791K ﹤0.01% 3309
2021
Q4
$1.69M Buy
176,118
+8,241
+5% +$78.9K ﹤0.01% 3615
2021
Q3
$1.49M Buy
167,877
+155,746
+1,284% +$1.38M ﹤0.01% 3706
2021
Q2
$149K Buy
+12,131
New +$149K ﹤0.01% 5024
2021
Q1
Sell
-22,741
Closed -$348K 5298
2020
Q4
$348K Buy
22,741
+1,072
+5% +$16.4K ﹤0.01% 4014
2020
Q3
$402K Buy
+21,669
New +$402K ﹤0.01% 3770
2019
Q2
Sell
-1,285
Closed -$10K 4227
2019
Q1
$10K Buy
1,285
+985
+328% +$7.67K ﹤0.01% 4150
2018
Q4
$2K Sell
300
-337
-53% -$2.25K ﹤0.01% 4059
2018
Q3
$7K Sell
637
-138
-18% -$1.52K ﹤0.01% 4103
2018
Q2
$212K Sell
775
-4,052
-84% -$1.11M ﹤0.01% 3863
2018
Q1
$1.31M Buy
4,827
+3,892
+416% +$1.06M ﹤0.01% 3067
2017
Q4
$223K Buy
935
+617
+194% +$147K ﹤0.01% 3780
2017
Q3
$64K Sell
318
-5,513
-95% -$1.11M ﹤0.01% 4093
2017
Q2
$676K Buy
5,831
+4,217
+261% +$489K ﹤0.01% 3362
2017
Q1
$258K Buy
1,614
+29
+2% +$4.64K ﹤0.01% 3845
2016
Q4
$276K Sell
1,585
-423
-21% -$73.7K ﹤0.01% 3755
2016
Q3
$492K Sell
2,008
-276
-12% -$67.6K ﹤0.01% 3447
2016
Q2
$567K Sell
2,284
-565
-20% -$140K ﹤0.01% 3248
2016
Q1
$1.03M Buy
2,849
+1,227
+76% +$445K ﹤0.01% 2852
2015
Q4
$748K Buy
1,622
+771
+91% +$356K ﹤0.01% 3042
2015
Q3
$138K Buy
851
+481
+130% +$78K ﹤0.01% 4029
2015
Q2
$312K Buy
370
+115
+45% +$97K ﹤0.01% 3685
2015
Q1
$255K Sell
255
-1,204
-83% -$1.2M ﹤0.01% 3746
2014
Q4
$1.46M Sell
1,459
-712
-33% -$710K ﹤0.01% 2701
2014
Q3
$1.77M Sell
2,171
-161
-7% -$131K ﹤0.01% 2584
2014
Q2
$2.54M Buy
+2,332
New +$2.54M ﹤0.01% 2396